MuseCells under the microscope: 5-Year registry tracks Real-World outcomes
NCT ID NCT07645989
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This registry follows 5000 people who have received Dezawa MuseCells as part of their routine care for conditions like osteoarthritis, pain, and wound healing. Participants report their symptoms and any side effects through online surveys over five years. The goal is to understand the long-term safety and effectiveness of this cell therapy in real-world settings.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Dezawa MuseCells
- What this could lead to
- If successful, this registry could reveal whether MuseCells provide lasting symptom relief and safety for various conditions, guiding future treatments.
- What could go wrong
- This is an observational study, not a controlled trial, so results may be influenced by other factors. Long-term benefits or risks remain uncertain.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 5,000 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Jul 2026
An estimate. Start dates often move.
- Expected to finish
-
Dec 2031
An estimate. End dates often move.
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients who have undergone treatment with Dezawa MuseCells
- Ages
-
Up to 89 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Received Dezawa MuseCells® as Part of Routine Clinical Care 2. Patients ( and/or authorized representative) capable of providing informed consent and participating in long-term follow-up. 3. Willingness to Complete Online Survey Assessments 4. Participants must have reliable access to email or a mobile device and be willing to complete digital surveys at scheduled intervals over a 5-year period. 5. Diagnosis of a Condition for Which Dezawa MuseCells® Were Administered Includes, but is not limited to, neurologic, musculoskeletal, cardiovascular, immunologic, and systemic degenerative conditions. 6. Ability to Communicate in the Registry's Supported Language 7. Participants must be able to read and respond to registry surveys in the designated study language. 8. Enrollment Within 12 Months of MuseCell® Administration Exclusion Criteria: 1. Not Receive Dezawa MuseCells®-Individuals who have not been treated with Dezawa MuseCells® or received a counterfeit/non-licensed product cannot be included. 2. Unable or Unwilling to Provide Informed Consent Includes individuals with cognitive impairment who lack a legally authorized representative willing to consent on their behalf. 3. Inability to Participate in Long-Term Digital Follow-Up 4. Concurrent Participation in an Interventional Clinical Trial Affecting Outcomes 5. History of Malignancy Diagnosed Within the Past 12 Months 6. Excludes patients with active or recently treated cancer unless their treating physician determines participation poses no additional safety concerns. 7. Any Condition That, in the Investigator's Judgment, Would Compromise Data Quality 8. Use of Non-Licensed or Counterfeit "Muse-like" Cells Ensures that registry data reflect outcomes of authentic Dezawa MuseCells® produced under licensed methods. 9. Pregnant or Actively Breastfeeding at Time of Enrollment
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Longevity are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The study's own enquiry address
This study publishes an address for enquiries. See it below .
-
The places running it
2 sites in 2 countries. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Bioreset Medical
RECRUITINGNorth Palm Beach, Florida, 33408, United States
Contact Email: •••••@•••••
-
Regene Labs
RECRUITINGGuadalajara, Mexico
Contact Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a daily pill slow the visible signs of aging?
- Five simple signs could help nurses score surgical pain in turkish
- Can a shot of your own blood ease arthritic knees?
- Can green light glasses take the sting out of surgery?
- Can a Hands-On nerve technique ease Fibromyalgia's grip?
- Fixing broken ribs with surgery may cut pain better than drugs alone